Related Experiment Videos
Malignant hyperthermia in dental patients
Journal of the American Dental Association (1939)
|February 1, 1984
Summary
Malignant hyperthermia is a rare, life-threatening condition triggered by anesthesia in susceptible individuals. Early identification and available treatments can prevent fatalities from this hypermetabolic crisis.
Area of Science:
- Anesthesiology
- Medical Genetics
- Pharmacology
Background:
- Malignant hyperthermia (MH) is a severe hypermetabolic disorder with a genetic basis.
- It is primarily triggered by volatile anesthetic agents and succinylcholine.
- Fatalities have been documented in dental settings under general anesthesia.
Observation:
- MH can also be triggered by non-pharmacologic factors like stress, exercise, and muscle injury in susceptible individuals.
- Clinical presentation involves rapid temperature increase, muscle rigidity, and metabolic derangement.
- Identifying susceptible individuals and managing MH can be challenging due to its varied triggers and empiric treatment.
Findings:
- Established criteria exist for identifying individuals susceptible to malignant hyperthermia.
- Effective prophylactic and therapeutic agents for MH are available.
- This paper reviews MH features, diagnostic criteria, and management protocols.
Implications:
- Improved identification of susceptible patients can prevent MH episodes.
- Availability of prophylactic and therapeutic agents enhances patient safety during anesthesia.
- Understanding non-anesthetic triggers is crucial for managing MH in conscious patients.